El Tegaserod es un fármaco agonista parcial de los receptores de serotonina 5-HT4, desarrollado por Novartis.
Ancho |
|
C |
|
Ch EMBL |
|
Chem Spider ID |
|
rdfs:comment |
|
foaf:depiction | |
Drug Bank |
|
Embarazo AU |
|
Embarazo US |
|
H |
|
Imagen |
|
In Ch I |
|
In Ch IKey |
|
foaf:isPrimaryTopicOf | |
KEGG |
|
rdfs:label |
|
N |
|
Nombre IUPAC |
|
Número CAS |
|
O |
|
Peso Molecular |
|
Prefijo ATC |
|
Is foaf:primaryTopic of | |
Pub Chem |
|
SMILES |
|
Std In Ch I |
|
Std In Ch IKey |
|
dcterms:subject | |
Sufijo ATC |
|
dbpedia-owl:thumbnail | |
UNII |
|
prov:wasDerivedFrom | |
dbpedia-owl:wikiPageID |
|
dbpedia-owl:wikiPageLength |
|
dbpedia-owl:wikiPageOutDegree |
|
Is dbpedia-owl:wikiPageRedirects of | |
dbpedia-owl:wikiPageRevisionID |
|
prop-latam:wikiPageUsesTemplate | |
dbpedia-owl:wikiPageWikiLink | [12 values] |
Is dbpedia-owl:wikiPageWikiLink of |